WELL HEALTH TECHNOLOGIES COR (WELL.CA) Fundamental Analysis & Valuation
TSX:WELL • CA94947L1022
4.35 CAD
-0.09 (-2.03%)
Last: Mar 6, 2026, 07:00 PM
This WELL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
WELL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 13 industry peers in the Health Care Providers & Services industry. WELL has a bad profitability rating. Also its financial health evaluation is rather negative. WELL has a decent growth rate and is not valued too expensively.
1. WELL.CA Profitability Analysis
1.1 Basic Checks
- WELL had negative earnings in the past year.
- WELL had a negative operating cash flow in the past year.
- In multiple years WELL reported negative net income over the last 5 years.
- WELL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- WELL has a Return On Assets of -2.14%. This is comparable to the rest of the industry: WELL outperforms 46.15% of its industry peers.
- WELL's Return On Equity of -5.12% is in line compared to the rest of the industry. WELL outperforms 46.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- WELL has a Gross Margin of 39.97%. This is in the better half of the industry: WELL outperforms 69.23% of its industry peers.
- WELL's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for WELL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. WELL.CA Health Analysis
2.1 Basic Checks
- WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
- WELL has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, WELL has more shares outstanding
- The debt/assets ratio for WELL has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.13, we must say that WELL is in the distress zone and has some risk of bankruptcy.
- WELL has a Altman-Z score (1.13) which is comparable to the rest of the industry.
- WELL has a Debt/Equity ratio of 0.67. This is a neutral value indicating WELL is somewhat dependend on debt financing.
- The Debt to Equity ratio of WELL (0.67) is better than 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.13 |
ROIC/WACCN/A
WACC7.86%
2.3 Liquidity
- WELL has a Current Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
- WELL has a better Current ratio (0.92) than 76.92% of its industry peers.
- A Quick Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
- With a decent Quick ratio value of 0.92, WELL is doing good in the industry, outperforming 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. WELL.CA Growth Analysis
3.1 Past
- WELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
- The Revenue has grown by 26.20% in the past year. This is a very strong growth!
- WELL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.78% yearly.
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
3.2 Future
- The Earnings Per Share is expected to grow by 19.72% on average over the next years. This is quite good.
- WELL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.80% yearly.
EPS Next Y110.8%
EPS Next 2Y66.77%
EPS Next 3Y37.7%
EPS Next 5Y19.72%
Revenue Next Year41.49%
Revenue Next 2Y25.39%
Revenue Next 3Y18.84%
Revenue Next 5Y15.8%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. WELL.CA Valuation Analysis
4.1 Price/Earnings Ratio
- WELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- WELL is valuated reasonably with a Price/Forward Earnings ratio of 10.43.
- Based on the Price/Forward Earnings ratio, WELL is valued cheaper than 84.62% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.57. WELL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.43 |
4.2 Price Multiples
- 69.23% of the companies in the same industry are more expensive than WELL, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.37 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- WELL's earnings are expected to grow with 37.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.77%
EPS Next 3Y37.7%
5. WELL.CA Dividend Analysis
5.1 Amount
- No dividends for WELL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
WELL.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:WELL (3/6/2026, 7:00:00 PM)
4.35
-0.09 (-2.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-25 2026-03-25/amc
Inst Owners3.95%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap1.10B
Revenue(TTM)1.21B
Net Income(TTM)-43.25M
Analysts82
Price Target7.78 (78.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.08%
Min EPS beat(2)-41.18%
Max EPS beat(2)-32.99%
EPS beat(4)0
Avg EPS beat(4)-244.03%
Min EPS beat(4)-696.08%
Max EPS beat(4)-32.99%
EPS beat(8)2
Avg EPS beat(8)1902.08%
EPS beat(12)3
Avg EPS beat(12)1068.91%
EPS beat(16)3
Avg EPS beat(16)736.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-1.25%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)3
Avg Revenue beat(8)-1.47%
Revenue beat(12)5
Avg Revenue beat(12)-0.69%
Revenue beat(16)9
Avg Revenue beat(16)0.18%
PT rev (1m)-0.25%
PT rev (3m)-0.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.76%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.43 | ||
| P/S | 0.91 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.37 |
EPS(TTM)-0.12
EYN/A
EPS(NY)0.42
Fwd EY9.59%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.76
BVpS3.32
TBVpS-2.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score1
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.23 | ||
| Cap/Depr | 27.43% | ||
| Cap/Sales | 2.1% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.13 |
F-Score1
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y110.8%
EPS Next 2Y66.77%
EPS Next 3Y37.7%
EPS Next 5Y19.72%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
Revenue Next Year41.49%
Revenue Next 2Y25.39%
Revenue Next 3Y18.84%
Revenue Next 5Y15.8%
EBIT growth 1Y-102.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.62%
EBIT Next 3Y65.63%
EBIT Next 5Y47.63%
FCF growth 1Y-170.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-132.25%
OCF growth 3Y-22.85%
OCF growth 5YN/A
WELL HEALTH TECHNOLOGIES COR / WELL.CA FAQ
What is the ChartMill fundamental rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to WELL.CA.
Can you provide the valuation status for WELL HEALTH TECHNOLOGIES COR?
ChartMill assigns a valuation rating of 5 / 10 to WELL HEALTH TECHNOLOGIES COR (WELL.CA). This can be considered as Fairly Valued.
What is the profitability of WELL stock?
WELL HEALTH TECHNOLOGIES COR (WELL.CA) has a profitability rating of 2 / 10.